Mycophenolate mofetil vs cyclophosphamide
Serious adverse events · adults with renal vasculitis
Mycophenolate mofetil may leads to higher serious adverse events compared with cyclophosphamide (low certainty).
1 finding from 1 review
- RR 1.251 study · 140 participantsLow